Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              ALTITUDE-AD: Use of a Validated Plasma pTau217 Assay to Screen Potential Participants in an Ongoing Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Sabirnetug for Early Alzheimer's Disease

              Author:Feaster, H Todd   Sundell, Karen   Hyland, Maddelyn   Sethuraman, Gopalan   Skljarevski, Vladimir   Kaplow, June   Dean, Robert A.   Jerecic, Jasna   Siemers, Eric   

              Session Name:S15: Innovations in Alzheimer's Diagnostics  

              Topic:Aging, Dementia, and Behavioral Neurology  

              Program Number:S15.008  

              Author Institution:

              INTERCEPT-AD Biomarker Results: Early Effect of Sabirnetug Treatment on Synaptic Biomarkers in Alzheimer's Disease

              Author:Johnson, Elizabeth   Cline, Erika N   Sundell, Karen   Antwi-Berko, Daniel   Koel-Simmelink, Marleen JA   Teunissen, Charlotte   Siemers, Eric   Zhang, Hao   Hyland, Maddelyn   Sethuraman, Gopalan   Vanderstichele, Hugo   Kaplow, June   Dean, Robert A   Jerecic, Jasna   

              Session Name:P12: Aging, Dementia, and Behavioral Neurology: Alzheimer's Treatment  

              Topic:Aging, Dementia, and Behavioral Neurology  

              Program Number:P12.003  

              Author Institution: